Early and late recurrence after hepatectomy in patients with low-level HBV-DNA hepatocellular carcinoma under antiviral therapy

BACKGROUND: Antiviral therapy has been shown to benefit long-term survival after curative hepatectomy in patients with hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC) with high levels of HBV-DNA, but the impact of antiviral therapy on patient recurrence in patients with low levels...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ziqiang, Tan, Chengpeng, Liu, Xiaohong, Feng, Zhe, Li, Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673293/
https://www.ncbi.nlm.nih.gov/pubmed/36397089
http://dx.doi.org/10.1186/s13027-022-00468-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673293/
https://www.ncbi.nlm.nih.gov/pubmed/36397089
http://dx.doi.org/10.1186/s13027-022-00468-6

Ejemplares similares